
Prompt:
Identify the key legal concepts and principles related to the provided laws.
I will provide a context, which will follow the label "Context:"


Context: {'id': 'Part164SubpartE', 'data': 'Subpart E—Privacy of Individually Identifiable Health Information'}, {'id': '164.500(b)(1)(vi)', 'data': '(vi) Section 164.532 relating to transition requirements; and '}, {'id': '164.508(a)(2)', 'data': '(2) Authorization required: Psychotherapy notes.  Notwithstanding any provision of this subpart, other than the transition provisions in § 164.532, a covered entity must obtain an authorization for any use or disclosure of psychotherapy notes, except: '}, {'id': '164.508(a)(3)(i)', 'data': '(i) Notwithstanding any provision of this subpart, other than the transition provisions in § 164.532, a covered entity must obtain an authorization for any use or disclosure of protected health information for marketing, except if the communication is in the form of: '}, {'id': '164.508(a)(4)(i)', 'data': '(i) Notwithstanding any provision of this subpart, other than the transition provisions in § 164.532, a covered entity must obtain an authorization for any disclosure of protected health information which is a sale of protected health information, as defined in § 164.501 of this subpart. '}, {'id': '164.532(a)', 'data': '(a) Standard: Effect of prior authorizations.  Notwithstanding §§ 164.508 and 164.512(i), a covered entity may use or disclose protected health information, consistent with paragraphs (b) and (c) of this section, pursuant to an authorization or other express legal permission obtained from an individual permitting the use or disclosure of protected health information, informed consent of the individual to participate in research, a waiver of informed consent by an IRB, or a waiver of authorization in accordance with § 164.512(i)(1)(i). '}, {'id': '164.532(b)', 'data': '(b) Implementation specification: Effect of prior authorization for purposes other than research.  Notwithstanding any provisions in § 164.508, a covered entity may use or disclose protected health information that it created or received prior to the applicable compliance date of this subpart pursuant to an authorization or other express legal permission obtained from an individual prior to the applicable compliance date of this subpart, provided that the authorization or other express legal permission specifically permits such use or disclosure and there is no agreed-to restriction in accordance with § 164.522(a). '}, {'id': '164.532(c)', 'data': '(c) Implementation specification: Effect of prior permission for research.  Notwithstanding any provisions in §§ 164.508 and 164.512(i), a covered entity may, to the extent allowed by one of the following permissions, use or disclose, for research, protected health information that it created or received either before or after the applicable compliance date of this subpart, provided that there is no agreed-to restriction in accordance with § 164.522(a), and the covered entity has obtained, prior to the applicable compliance date, either: '}, {'id': '164.532(d)', 'data': '(d) Standard: Effect of prior contracts or other arrangements with business associates.  Notwithstanding any other provisions of this part, a covered entity, or business associate with respect to a subcontractor, may disclose protected health information to a business associate and may allow a business associate to create, receive, maintain, or transmit protected health information on its behalf pursuant to a written contract or other written arrangement with such business associate that does not comply with §§ 164.308(b), 164.314(a), 164.502(e), and 164.504(e), only in accordance with paragraph (e) of this section. '}, {'id': '164.532(e)', 'data': '(e) Implementation specification: Deemed compliance —'}, {'id': '164.532(f)', 'data': '(f) Effect of prior data use agreements.  If, prior to January 25, 2013, a covered entity has entered into and is operating pursuant to a data use agreement with a recipient of a limited data set that complies with § 164.514(e), notwithstanding § 164.502(a)(5)(ii), the covered entity may continue to disclose a limited data set pursuant to such agreement in exchange for remuneration from or on behalf of the recipient of the protected health information until the earlier of: '}, {'id': 'Part164SubpartE', 'data': 'Subpart E—Privacy of Individually Identifiable Health Information'}, {'id': '164.532(a)', 'data': '(a) Standard: Effect of prior authorizations.  Notwithstanding §§ 164.508 and 164.512(i), a covered entity may use or disclose protected health information, consistent with paragraphs (b) and (c) of this section, pursuant to an authorization or other express legal permission obtained from an individual permitting the use or disclosure of protected health information, informed consent of the individual to participate in research, a waiver of informed consent by an IRB, or a waiver of authorization in accordance with § 164.512(i)(1)(i). '}, {'id': '164.532(b)', 'data': '(b) Implementation specification: Effect of prior authorization for purposes other than research.  Notwithstanding any provisions in § 164.508, a covered entity may use or disclose protected health information that it created or received prior to the applicable compliance date of this subpart pursuant to an authorization or other express legal permission obtained from an individual prior to the applicable compliance date of this subpart, provided that the authorization or other express legal permission specifically permits such use or disclosure and there is no agreed-to restriction in accordance with § 164.522(a). '}, {'id': '164.532(c)', 'data': '(c) Implementation specification: Effect of prior permission for research.  Notwithstanding any provisions in §§ 164.508 and 164.512(i), a covered entity may, to the extent allowed by one of the following permissions, use or disclose, for research, protected health information that it created or received either before or after the applicable compliance date of this subpart, provided that there is no agreed-to restriction in accordance with § 164.522(a), and the covered entity has obtained, prior to the applicable compliance date, either: '}, {'id': '164.532(d)', 'data': '(d) Standard: Effect of prior contracts or other arrangements with business associates.  Notwithstanding any other provisions of this part, a covered entity, or business associate with respect to a subcontractor, may disclose protected health information to a business associate and may allow a business associate to create, receive, maintain, or transmit protected health information on its behalf pursuant to a written contract or other written arrangement with such business associate that does not comply with §§ 164.308(b), 164.314(a), 164.502(e), and 164.504(e), only in accordance with paragraph (e) of this section. '}, {'id': '164.532(e)', 'data': '(e) Implementation specification: Deemed compliance —'}, {'id': '164.532(f)', 'data': '(f) Effect of prior data use agreements.  If, prior to January 25, 2013, a covered entity has entered into and is operating pursuant to a data use agreement with a recipient of a limited data set that complies with § 164.514(e), notwithstanding § 164.502(a)(5)(ii), the covered entity may continue to disclose a limited data set pursuant to such agreement in exchange for remuneration from or on behalf of the recipient of the protected health information until the earlier of: '}, {'id': '164.500(b)(1)(vi)', 'data': '(vi) Section 164.532 relating to transition requirements; and '}, {'id': '164.508(a)(2)', 'data': '(2) Authorization required: Psychotherapy notes.  Notwithstanding any provision of this subpart, other than the transition provisions in § 164.532, a covered entity must obtain an authorization for any use or disclosure of psychotherapy notes, except: '}, {'id': '164.508(a)(3)(i)', 'data': '(i) Notwithstanding any provision of this subpart, other than the transition provisions in § 164.532, a covered entity must obtain an authorization for any use or disclosure of protected health information for marketing, except if the communication is in the form of: '}, {'id': '164.508(a)(4)(i)', 'data': '(i) Notwithstanding any provision of this subpart, other than the transition provisions in § 164.532, a covered entity must obtain an authorization for any disclosure of protected health information which is a sale of protected health information, as defined in § 164.501 of this subpart. '}


Output Struct:
{ 
	"key legal concepts": ["explanation of concept 1", "explanation of concept 2", ...], 
	"key legal principles": ["explanation of principle 1", "explanation of principle 2", ...],
	"application scenarios": ["something", "something"],
	"relationship to overall document argument": ["something", "something"]
}


You should focus solely on explaining THIS LAW within the given context:
THIS LAW:
{'id': '164.532', 'data': '§ 164.532 Transition provisions.'}
You may now respond.
